Skip to main navigation

Press Releases

Press Releases

Year

May 31, 2024

Personalis Announces Start of Cancer MRD Testing Commercialization Collaboration with Tempus

May 22, 2024

Personalis Announces Podium Presentations and Abstracts Accepted at ASCO 2024

May 17, 2024

Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 08, 2024

Personalis Reports First Quarter 2024 Financial Results

Apr 24, 2024

Personalis to Announce First Quarter 2024 Financial Results

Mar 28, 2024

Personalis to Present at the 23rd Annual Needham Virtual Healthcare Conference

Mar 28, 2024

Data Showcasing NeXT Personal MRD Test to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting

Mar 26, 2024

Personalis Announces Publication Validating NeXT Personal® Test for Ultra-sensitive MRD Detection and Cancer Treatment Response Monitoring

Mar 19, 2024

Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Feb 28, 2024

Personalis Reports Fourth Quarter and Full Year 2023 Financial Results

Pagination

First page
Previous page
Page 1
Current page 2
Page 3
Next page
Last page

Displaying 11 - 20 of 26

Print Page

RSS Feeds

Email Alerts

Contact IR

Corporate Website